fda declares semaglutide shortage over declaratory order resolved feb 21 2025 february Drug compounders sue FDA declaration ending Wegovy shortage FDA end to Wegovy – Under The Hood, Novo Nordisk – FDA Issues Order on Resolution

It is not intended for human consumption, medical use, diagnostic use, therapeutic use, weight-loss use, appetite-control use, glucose-management use, diabetes treatment use, obesity treatment use, supplement use, injection use, or the treatment, prevention, or diagnosis of any disease

The 1.4% gallbladder complication rate in clinical trials was almost entirely concentrated among participants who went too low on fat

Not peptides, but commonly offered alongside them Under FDA review BPC-157, TB-500, KPV, MOTS-C on the July 2026 agenda DSIP, Semax, Epitalon on the July 2026 agenda GHK-Cu second review by Feb 2027 CJC-1295 and Ipamorelin were declined in 2024 and remain restricted, not coming back via this process

Yes, it is compatible with 3 ml cartridges from all major brands and supports 1 ml and 2.25 ml PFS